News & Analysis on Clinical Trial Services & Contract Research And Development
DFE Pharma: sMCC 90 excipient
By Jenni Spinner
- Last updated on
DFE Pharma has released Pharmacel sMCC 90, a silicified microcrystalline cellulose (MCC). The new product is designed to offer a synergistic solution for challenging oral solid dosage formulations.
CEO Bas van Driel commented: “Pharmacel sMCC 90 is an ideal excipient that improves tablet compression and aids higher production speed, thereby enabling rapid formulation development. We always put innovation at the heart of our business, thereby bringing excipients with multiple functionality benefits to our customers to meet their formulation needs.”